Published in Medical Letter on the CDC and FDA, May 20th, 2007
Receiving its first FDA indication for the treatment of wrinkles and rhytids, the Accent system has been used successfully by medical professionals worldwide to treat a variety of dermatological and aesthetic conditions.
"We're delighted to receive the marketing clearance for the Accent product in the United States," stated Howard Kelly, CEO for Alma Lasers. "The unique dual mode...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.